Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects.
Moscetti L, Hennik P, Bolstad B, Camarero J, Josephson F, Melchiorri D, Sommerfelt Grønvold M, Sjoberg J, Botezatu M, Mulder J, Meulendijks D, Trullas Jimeno A, Zafiropoulos N, Bergh J, Enzmann H, Pignatti F.
Moscetti L, et al. Among authors: zafiropoulos n.
ESMO Open. 2020 Aug;5(4):e000856. doi: 10.1136/esmoopen-2020-000856.
ESMO Open. 2020.
PMID: 32847837
Free PMC article.
Review.